PRESS RELEASE published on 08/14/2026 at 07:30, 28 days 4 hours ago adesso SE reports dynamic sales growth of 13% and a disproportionately high increase in EBITDA of 21% for the first half of the year / Full-year forecast confirmed adesso SE reports 13% sales growth and 21% EBITDA increase in H1 2026. Full-year forecast confirmed. GenAI drives growth in cloud transformation and AI Sales Growth Adesso SE EBITDA Increase GenAI Full-year Forecast
PRESS RELEASE published on 08/14/2026 at 07:30, 28 days 4 hours ago SFC Energy achieves record first half with a strong increase in profitability – Forecast 2026 narrowed on the upside SFC Energy AG achieves record first half with a strong increase in profitability. Forecast for 2026 narrowed on the upside, highlighting growth and strategic positioning Profitability Forecast Growth SFC Energy AG Strategic Positioning
PRESS RELEASE published on 08/14/2026 at 07:25, 28 days 4 hours ago Blackhat Strategy Unveils Guide to Choosing a Kratom Advertising Agency for Restricted Industries Phoenix, Arizona, USA, August 14th, 2026, FinanceWire
PRESS RELEASE published on 08/14/2026 at 07:19, 28 days 4 hours ago NORMA Group launches second public share buyback offer with a total volume of approximately EUR 208 million NORMA Group launches second public share buyback offer totaling approximately EUR 208 million. Offer price at EUR 22.35 per share includes a 25.47% premium. Company aims to complete capital return to shareholders Share Buyback Premium Capital Return NORMA Group Disciplined Capital Allocation
PRESS RELEASE published on 08/14/2026 at 07:17, 28 days 4 hours ago EQS-Adhoc: NORMA Group SE: Management Board initiates public share buyback offer with a volume of approximately EUR 208 million for up to a total of 9,306,487 shares NORMA Group SE Management Board initiates public share buyback offer of approximately EUR 208 million for up to 9,306,487 shares, following the resolution at the Annual General Meeting Share Buyback Management Board Public Offer NORMA Group SE EUR 208 Million
PRESS RELEASE published on 08/14/2026 at 07:00, 28 days 4 hours ago Ringmetall expands to South Africa and strengthens Liner business division with majority stake in bag-in-box producers Ringmetall acquires majority stake in bag-in-box producer Tesseraux SA in South Africa, expanding Liner business division and entering African market Expansion South Africa Ringmetall Bag-in-box Tesseraux SA
PRESS RELEASE published on 08/14/2026 at 07:00, 28 days 4 hours ago Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency European Medicines Agency validates Pfizer and Valneva's MAA for Lyme Disease Vaccine Candidate based on Phase 3 results. Potential game-changer in Lyme disease prevention Valneva Lyme Disease Vaccine Pfizer European Medicines Agency Phase 3 VALOR Trial
PRESS RELEASE published on 08/14/2026 at 07:00, 28 days 4 hours ago Pfizer et Valneva annoncent l’acceptation pour revue par l’Agence européenne des médicaments (EMA) de la demande d’autorisation de mise sur le marché de leur candidat vaccin contre la maladie de Lyme Pfizer et Valneva soumettent leur candidat vaccin hexavalent contre la maladie de Lyme à l'examen de l'EMA. Le vaccin PF-07307405 présente une efficacité de plus de 70 % selon l'étude VALOR Valneva Maladie De Lyme Pfizer Vaccin EMA
PRESS RELEASE published on 08/14/2026 at 06:58, 28 days 5 hours ago Nagarro presents Q2 and H1 2026 numbers, posts 2.0% and 4.2% YoY revenue growth in constant currency in Q2 and H1 2026, respectively Nagarro SE presents Q2 and H1 2026 financial results with 2.0% and 4.2% YoY revenue growth in constant currency. EBITDA and net profit details shared Financial Results Revenue Growth Nagarro SE Q2 2026 H1 2026
PRESS RELEASE published on 08/14/2026 at 06:55, 28 days 5 hours ago STRATEC POSTS RESULTS FOR FIRST HALF OF 2026 STRATEC SE reports 3.3% decrease in sales for H1 2026 but sees significant profitability improvement in Q2 2026. Guidance confirms sales growth expected in medium to high single-digit percentage range with adjusted EBIT margin similar to 2025 Financial Results Profitability Improvement STRATEC SE Sales Decrease 2026 Guidance
Published on 09/11/2026 at 04:00, 7 hours 59 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 34 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 39 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 59 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 16 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 24 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 29 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 1 hour 44 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 4 hours 59 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 59 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 59 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 29 minutes ago Availability of the 2026 Interim Financial Report